Skip to main content

Spectrum: Autism Research News

Tag: mGluR5

November 2021

Fragile X theory falters on amygdala test

by  /  10 November 2021

Activating certain receptors in the amygdala — a treatment that runs counter to a leading theory of what causes the condition — can reverse some traits in rats.

0 Comments
May 2021
Dr. Elizabeth Berry-Kravis stretching during a run.

Elizabeth Berry-Kravis: Running a marathon for fragile X syndrome

by  /  26 May 2021

Elizabeth Berry-Kravis has spent decades uncovering molecular clues to fragile X syndrome and crafting trials of treatments. Her efforts are paying off.

0 Comments
March 2021
Hands of researcher in two colors, one hand with Fragile X and the other with COIVD shapes connected by multicolored dots.

Fragile X researcher takes on COVID-19

by  /  2 March 2021

Cara Westmark has spent the past year building the case that a drug designed for fragile X syndrome might help coronavirus patients, too.

0 Comments
October 2020
Ralf Schmid, the research director in Neurodevelopmental diseases at the Gene Therapy Program Orphan Disease Center, loads replicated mouse dna into wells in the gel before applying electric current to test the viability of the dna.

A quest for Quincy: Gene therapies come of age for some forms of autism

by ,  /  14 October 2020

A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.

0 Comments
October 2019

Mouse study hints at why fragile X drugs fail in trials

by  /  22 October 2019

Drug after drug has failed in clinical trials for fragile X syndrome. A new study provides an explanation — a decrease in the drugs’ effectiveness over time — and points to a new strategy that could circumvent this problem.

0 Comments
October 2018
Illustration of research mice forming the letter 'X'.

Fragile X syndrome’s link to autism, explained

by  /  10 October 2018

Fragile X syndrome is a leading genetic cause of autism. People who have either condition often share certain traits, such as difficulties in social situations.

0 Comments
September 2018
Drawing shows scientists moving in different directions in a matrix of molecules and and genetic material.

Newly discovered aspects of fragile X spur next wave of drugs

by  /  24 September 2018

Many drugs for fragile X syndrome have failed in large clinical trials, but candidates that target new aspects of the condition may fare better.

0 Comments
June 2018
Week of JuneJun
25th
2018

Smart genes; Neanderthal mini-brains; diabetes link and more

by  /  29 June 2018

Autism and intelligence share genetic variants, researchers grow Neanderthal mini-brains and see overlap with autism, and maternal diabetes is an autism risk factor.

0 Comments
May 2018
Microscopic image of skin cells

Study challenges theory that protein surplus underlies fragile X

by  /  16 May 2018

Many people with fragile X syndrome show average rates of protein production, challenging a long-held assumption about the condition.

0 Comments
November 2017
Mapping the connections between brain regions in mice can reveal which ones are strengthened by a drug.

Mouse imaging study hints at how fragile X drug trial went wrong

by  /  15 November 2017

The drug mavoglurant has no effect on a brain circuit involved in social behavior in a mouse model of fragile X syndrome. That may explain its poor performance in people with the condition.

0 Comments